Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Net Cash Flow (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Net Cash Flow readings, the most recent being -$13.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 184.91% year-over-year to -$13.0 million, compared with a TTM value of $53.9 million through Dec 2025, down 11.6%, and an annual FY2025 reading of $53.9 million, down 11.6% over the prior year.
  • Net Cash Flow hit -$13.0 million in Q4 2025 for Apellis Pharmaceuticals, down from $109.1 million in the prior quarter.
  • The five-year high for Net Cash Flow was $356.4 million in Q4 2021, with the low at -$298.4 million in Q1 2021.
  • Median Net Cash Flow over the past 5 years was -$9.9 million (2022), compared with a mean of -$4.9 million.
  • The largest YoY upside for Net Cash Flow was 3233.39% in 2023 against a maximum downside of 717.05% in 2023.
  • Year by year, Net Cash Flow stood at $356.4 million in 2021, then crashed by 109.14% to -$32.6 million in 2022, then crashed by 212.59% to -$101.8 million in 2023, then skyrocketed by 115.07% to $15.3 million in 2024, then tumbled by 184.91% to -$13.0 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$13.0 million, $109.1 million, and $11.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.